Induction of NRF2‐mediated gene expression by dietary phytochemical flavones apigenin and luteolin
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Apigenin (API) and luteolin (LUT) have been used as therapeutic agents in folk medicine for thousands of years. These compounds exert a variety of biological activities, including anticancer, antioxidant and antiinflammatory activities. This study investigated whether API and LUT could activate Nrf2‐antioxidant response element (ARE)‐mediated gene expression and induce antiinflammatory activities in human hepatoma HepG2 cells. The compounds did not exhibit any substantial toxicity at low doses (1.56–6.25 µ m). The induction of ARE activity was assessed in HepG2‐C8 cells after treatment with low doses of API and LUT for 6 and 12 h. It was found that the induction of ARE activity by these compounds at the higher doses was comparable to the effects of the positive control, SFN at a dose of 6.25 µ m. Exposure to the PI3K inhibitor LY294002 abolished ARE activation by both API and LUT, whereas the ERK‐1/2 inhibitor PD98059 only decreased ARE activity induced by API. Both compounds significantly increased the endogenous mRNA and protein levels of Nrf2 and Nrf2 target genes with important effects on heme oxygenase‐1 (HO‐1) expression. API and LUT significantly and dose‐dependently decreased the production of nitric oxide (NO), nitric oxide synthase (iNOS) and cytosolic phospholipase A2 (cPLA2), which were induced by the treatment of HepG2 cells with 1 µg/ml of lipopolysaccharide (LPS) for 24 h. The results indicate that API and LUT significantly activate the PI3K/Nrf2/ARE system, and this activation may be responsible for their antiinflammatory effects, as demonstrated by the suppression of LPS‐induced NO, iNOS and cPLA2. Copyright © 2015 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LPS/TLR4 signal transduction pathway
Lu, Y.-C., Yeh, W.-C., & Ohashi, P. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.01.006 · Cited by 3,301
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · cited 1×
“Activated TLR4 induces the expression of a broad spectrum of mediators, including inducible nitric oxide synthase (iNOS), which has been shown to depend on NF-κB activation [43].”
BackgroundMechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241 · cited 1×
“Although the mechanism by which Nrf2 modulates inflammatory signals is not fully understood, some studies suggest that the Nrf2 target gene HO-1 may be involved in this activity because its upregulation has been correlated with cytoprotective effects in various inflammatory diseases [40].”
BackgroundBenavente-García, O., & Castillo, J. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8006568 · Cited by 1,158 · cited 2×
“activities, including the modulation of inflammation and carcinogenesis, and thus constitute promising molecules for cancer prevention [4,33].”
BackgroundNrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
Thimmulappa, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25790 · Cited by 1,028
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Li, W., Khor, T. O., Xu, C., Shen, G., Jeong, W.-S., Yu, S., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.017 · Cited by 738
Self-citationLiu, G.-H., Qu, J., & Shen, X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.002 · Cited by 697
Flavonols, Flavones, Flavanones, and Human Health: Epidemiological Evidence
Graf, B. A., Milbury, P. E., & Blumberg, J. B. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.281 · Cited by 556 · cited 1×
“API and LUT intake has been associated with a decreased risk of several types of cancer [4,5].”
BackgroundIncreased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer
Khor, T. O., Huang, M.-T., Prawan, A., Liu, Y., Hao, X., Yu, S., Cheung, W. K. L., Chan, J. Y., Reddy, B. S., Yang, C. S., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0028 · Cited by 306
Self-citation
Research works printed but not linked: 41
- 10.1016/j.pharmthera.2012.09.008 · DOI · Paper page
- 10.4103/0973-7847.134247 · DOI · Paper page
- 10.1021/jf062088r · DOI
- 10.1016/S0163-7258(01)00137-1 · DOI · Paper page
- 10.2174/156800908786241050 · DOI · Paper page
- 10.1007/s11095-010-0089-7 · DOI · Paper page
- 10.1016/j.cbi.2011.06.009 · DOI
- Hwang J‐T, 2011, Anti‐tumor effect of luteolin is accompanied by AMP‐activated protein kinase and nuclear factor‐kappaB modulation in HepG2 hepatocarcinoma cells, Int J Mol Med, 28, 25
- 10.1016/j.cell.2011.02.013 · DOI · Paper page
- 10.1002/bdd.759 · DOI · Paper page
- 10.1093/carcin/bgs358 · DOI
- 10.1007/128_2012_340 · DOI · Paper page
- 10.1007/s00204-012-0913-4 · DOI · Paper page
- 10.1208/s12248-014-9613-8 · DOI
- 10.3109/10408449309104073 · DOI · Paper page
- 10.1016/j.biochi.2013.04.012 · DOI · Paper page
- 10.1002/mc.21950 · DOI
- 10.1038/srep03242 · DOI · Paper page
- 10.1002/mc.20725 · DOI · Paper page
- 10.1186/2045-3701-4-39 · DOI · Paper page
- 10.4049/jimmunol.179.10.7121 · DOI · Paper page
- 10.1164/ajrccm.165.6.2101049 · DOI · Paper page
- 10.1002/bdd.1846 · doi:10.1002/bdd.1846
- 10.1016/j.etap.2013.01.009 · DOI
- 10.1007/BF02977329 · DOI
- 10.4049/jimmunol.177.4.2592 · DOI · Paper page
- 10.1371/journal.pone.0090739 · DOI
- 10.1016/j.intimp.2007.11.003 · DOI · Paper page
- Noroozi M, 1998, Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes, Am J Clin Nutr, 67, 1210, 10.1093/ajcn/67.6.1210 · DOI · Paper page
- 10.1016/j.bcp.2012.11.016 · DOI · Paper page
- 10.1371/journal.pone.0006588 · DOI · Paper page
- 10.1089/ars.2010.3276 · DOI · Paper page
- 10.1074/jbc.M113.540633 · DOI · Paper page
- 10.1023/B:PHAM.0000022413.43212.cf · DOI · Paper page
- 10.1126/science.1112304 · DOI · Paper page
- 10.1016/S0027-5107(01)00183-X · DOI · Paper page
- 10.1172/JCI119782 · DOI · Paper page
- 10.1093/carcin/20.10.1945 · DOI · Paper page
- 10.4162/nrp.2013.7.6.423 · DOI
- 10.1097/01.MP.0000052101.58988.1F · DOI
- 10.1371/journal.pone.0069688 · doi:10.1371/journal.pone.0069688
Cited by
The Therapeutic Potential of Apigenin
Salehi, B., Venditti, A., Sharifi-Rad, M., Kręgiel, D., Sharifi-Rad, J., Durazzo, A., Lucarini, M., Santini, A., Souto, E. B., Novellino, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061305 · Cited by 1,238
Nrf2 in cancers: A double‐edged sword
Wu, S., Lu, H., & Bai, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2101 · Cited by 465
Health functionality of apigenin: A review
Ali, F., Rahul, Naz, F., Jyoti, S., & Siddique, Y. H. (2017) · International Journal of Food Properties · doi:10.1080/10942912.2016.1207188 · Cited by 343
Thiruvengadam, M., Venkidasamy, B., Subramanian, U., Samynathan, R., Ali Shariati, M., Rebezov, M., Girish, S., Thangavel, S., Dhanapal, A. R., Fedoseeva, N., et al. (2021) · Antioxidants · doi:10.3390/antiox10121859 · Cited by 279
Pohl, F., & Kong Thoo Lin, P. (2018) · Molecules · doi:10.3390/molecules23123283 · Cited by 272
Thirty years of NRF2: advances and therapeutic challenges.
Zhang, D. D. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01145-0 · Cited by 282
Zhu, J., Wang, H., Chen, F., Fu, J., Xu, Y., Hou, Y., Kou, H. H., Zhai, C., Nelson, M. B., Zhang, Q., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.010 · Cited by 162
Gelabert-Rebato, M., Wiebe, J. C., Martin-Rincon, M., Galvan-Alvarez, V., Curtelin, D., Perez-Valera, M., Juan Habib, J., Pérez-López, A., Vega, T., Morales-Alamo, D., et al. (2019) · Nutrients · doi:10.3390/nu11020344 · Cited by 49
Gelabert-Rebato, M., Wiebe, J. C., Martin-Rincon, M., Gericke, N., Perez-Valera, M., Curtelin, D., Galvan-Alvarez, V., Lopez-Rios, L., Morales-Alamo, D., & Calbet, J. A. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00740 · Cited by 33
Metadata
- Authors
- Paredes‐Gonzalez, X., Fuentes, F., Jeffery, S., Saw, C. L., Shu, L., Su, Z., & Kong, A. T.
- Venue
- Biopharmaceutics & Drug Disposition
- Publisher
- Wiley
- Published
- 2015-07-15
- Volume
- 36
- Issue
- 7
- Pages
- 440-451
- ISSN
- 0142-2782 (ISSN-L)
- 1099-081X
- OpenAlex
- W1580399005
- Cited by
- 118
- References
- 9
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- National Cancer Institute (R01‐CA118947, R01‐CA152826)
- National Center for Complementary and Alternative Medicine (R01AT007065)
- Office of Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.